News & Updates

Heavy lifetime use of cannabis among women contributes to increased risk of death from cardiovascular disease (CVD), as reported in a study.

In a phase IIb open-label trial, combination therapy with bulevirtide and peginterferon alfa-2a (pegIFNα) yields a synergistic on-treatment effect, with more patients achieving undetectable HDV RNA levels compared to bulevirtide alone.

For patients with chronic obstructive pulmonary disease (COPD) exacerbation, incorporating virtual reality in pulmonary rehabilitation is safe and helps increase motivation to participate in treatment programs, according to a study.

The latest update of the model for end-stage liver disease (MELD), MELD 3.0, predicts mortality in multiethnic Asian patients hospitalized with cirrhosis with greater accuracy than previous models, according to a study from Singapore.

In the treatment of patients with a BMI of 50–60 kg/m2, duodenal switch (DS) appears to result in better weight loss outcomes but also more frequent adverse events, including nutritional complications, as compared with Roux-en-Y-gastric bypass (RYGB), according to an open-label study.

Bronchoscopic transbronchial lung cryobiopsy (TBLC), when done by capable hands, is a safe procedure for adult patients with unclassifiable interstitial lung disease (ILD), suggests a study.

Oxygen supplementation in patients with interstitial lung disease (ILD) who are undergoing high-flow nasal cannula (HFNC) therapy results in better exercise tolerance and percutaneous oxygen saturation (SpO2), a study has shown.

Current smoking and respiratory diseases independently contribute to coronary microvascular disease (CMD) in patients undergoing invasive coronary microvascular evaluation, suggests a study. Moreover, higher pack-years among smokers strongly predict CMD.